Cannabis Legalization Outcomes: What 329 Studies Found
Cannabis legalization outcomes across 329 studies included fewer possession arrests and generally more adult access and use. Youth prevalence did not rise uniformly, but pediatric exposure and acute-care signals remained important. Market and road-safety…
Cannabis legalization and law enforcement drug seizures: a state-level analysis of cannabis policy effects on cannabis seizures in the United States, 2010-2023.
A comprehensive 13-year analysis reveals that cannabis legalization reduces drug seizures significantly, with recreational programs showing greater impact than medical-only policies. This research demonstrates how cannabis legalization reduces drug…
Cannabis Legalization: A Global Overview of Trends, Use Patterns, and Health Risks
Cannabis legalization global trends show a rise in use prevalence and associated health risks. This overview highlights patterns and regulatory challenges worldwide. Understanding these trends is crucial for informed clinical guidance.
Canadian Cannabis Legalization Linked to Tens of Thousands of Estimated Annual Deaths—But the Numbers Require Careful Scrutiny
Cannabis-associated health risks contribute to an estimated 28,000 to 30,000 premature deaths annually in Canada. These figures derive from population-attributable fraction modelling rather than direct causal attribution. Understanding…
Pennsylvania House Passes Budget Plan Including Cannabis Revenue Projections
The Pennsylvania cannabis budget plan includes projected marijuana revenue despite legalization not yet in place. This budget plan signals strong legislative confidence in future cannabis legalization. Clinicians should prepare for changes affecting…
Not your parents’ cannabis: Legalization lights up innovation—but not clinical research
The cannabis clinical research gap widens as legalization fuels rapid product innovation without matching clinical trials. Patients access potent, diverse cannabis products, but clinicians lack robust evidence to guide safe use. This gap challenges…
Cannabis Legalization Spurs Innovation, But Not Always in Ways That Benefit Patients or Public Health
Cannabis market innovation impact is reshaping product availability but often prioritizes commercial appeal over patient benefits. This divergence complicates clinical practice and patient education. Understanding these challenges is essential for…
NYT Revises Marijuana Advocacy Amid Cultural Shift on Legalization
Media narratives cannabis legalization impact patient attitudes and clinical discussions significantly. The New York Times' editorial shift reflects a broader cultural reconsideration of cannabis policy. This change affects how patients perceive cannabis…
Does Cannabis Legalization Actually Lead to Better Health? – The Afternoon Story
The cannabis legalization push is reshaping public health landscapes with mixed outcomes. Evidence shows both benefits like reduced opioid use and challenges such as increased emergency visits. Clinicians must navigate these changes with informed…
‘Not Your Parents’ Cannabis: Legalization Lights Innovation — But Not Clinical Research
Cannabis clinical research innovation is evolving as legalization expands. Despite increased innovation, clinical research lags behind. This article explores key developments in cannabis medicine and clinical practice.